In my journey through the global healthtech and longevity — from WebSummit, where I met Pierre-Edouard Sottas, Founder & CEO at xLongevity, to earlier #Healthcare online meetups where I connected with Jin-Xiong She, PhD, Founder & CEO at Jinfiniti Precision Medicine — I had the privilege to engage with some of the brightest minds reshaping our understanding of #healthspan, #biomarkers, and precision health.
As Pierre-Edouard eloquently described in his recent posts (https://bit.ly/3GJHmdG, https://bit.ly/44geVhq), NAD⁺ is not just a molecule but the metabolic hub of health, resilience, and aging. His commitment to the accurate measurement of NAD⁺ levels (especially in PBMCs) is reshaping how we think about real longevity biomarkers.
Meanwhile, Jinfiniti Precision Medicine, under the leadership of Dr. She, is pioneering comprehensive longevity testing, including NAD⁺, senescence markers, oxidative stress levels, and inflammation indicators — all validated by over 400 peer-reviewed publications and decades of genomic research excellence.
Where do their visions intersect?
- Accurate Measurement: Both stress the critical need for meaningful, biologically relevant biomarkers rather than superficial or misleading indicators
- Personalized Interventions: xLongevity and Jinfiniti focus not just on diagnostics but actionable plans—ranging from targeted supplementation (e.g., NMN, NAD boosters) to precision health programs
- Scaling Preventive Health: Their missions aim to make longevity tools accessible to broader populations, not just the elite
Imagine a collaboration where:
- ✅ xLongevity’s holistic, AI-driven health coaching is powered by Jinfiniti’s precision biomarker panels
- ✅ Biologically accurate #NAD⁺ measurement protocols from Pierre-Edouard Sottas сomplements tailored interventions and supplement regimens designed by Dr. She’s methodologies
- ✅ Shared innovation in #NAD metabolism modulation, pairing diagnostics with therapeutic strategies to not just slow aging, but truly enhance healthspan
💬 My Take:
In the rapidly growing field of longevity science, synergistic collaborations between visionary leaders like Pierre-Edouard and Dr. She could accelerate breakthroughs that transform personalized health forever.
I hope to see future collaborations that combine clinical-grade biomarker science and AI-powered longevity optimization. 🚀
If you’re passionate about precision medicine, longevity, or next-gen healthcare solutions, definitely follow their work and contact us at YOUR R&D™!
🔗 Connect with them:
Pierre-Edouard Sottas https://xlongevity.com/
Jin-Xiong She, PhD https://www.jinfiniti.com/
At #YourRnD, we are always excited to support healthtech and longevity startups with AI development, precision health platforms, and scalable innovation models. Let’s build the future of healthy aging together!
#PrecisionMedicine #MedTech #AIinHealthcare #Biohacking
